Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Journal for Immunotherapy of Cancer|July 21, 2019
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patientsDaan P Hurkmans, Edwin A Basak, Tanja van Dijk, et al.
Contemporary Clinical Trials Communications|April 18, 2025
Pharmacokinetic boosting of olaparib: Study protocol of a multicentre, open-label, randomised, non-inferiority trial (PROACTIVE-B)Joanneke K Overbeek, Niels A D Guchelaar, Ma Ida Mohmaed Ali, et al.
British Journal of Clinical Pharmacology|August 10, 2021
Hyperhydration with cisplatin does not influence pemetrexed exposureNikki de Rouw, Hieronymus J Derijks, Luuk B Hilbrands, et al.
Breast Cancer Research and Treatment|August 18, 2020
Influence of green tea consumption on endoxifen steady-state concentration in breast cancer patients treated with tamoxifenC Louwrens Braal, Koen G A M Hussaarts, Lieke Seuren, et al.
NPJ Breast Cancer|August 5, 2023
CBD-oil as a potential solution in case of severe tamoxifen-related side effectsSanne M Buijs, C Louwrens Braal, Stefan A J Buck, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|August 29, 2025
Phase I study of intraperitoneal irinotecan with systemic capecitabine and oxaliplatin for patients with gastric peritoneal metastasesNiels A D Guchelaar, Marion W Tops-Welten, Pieter C van der Sluis, et al.
Lung Cancer (Amsterdam, Netherlands)|August 17, 2021
Randomized phase III study of docetaxel versus docetaxel plus intercalated erlotinib in patients with relapsed non-squamous non-small cell lung carcinomaChristi M J Steendam, Robert Peric, Nico C van Walree, et al.
Clinical Pharmacokinetics|June 13, 2023
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer PatientsRuben A G van Eerden, Nikki S IJzerman, Milan van Meekeren, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 14, 2023
Systemic exposure of floxuridine after hepatic arterial infusion pump chemotherapy with floxuridine in patients with resected colorectal liver metastasesNikki S IJzerman, Wills F Filipe, Peter de Bruijn, et al.
Eclinicalmedicine|May 1, 2023
Influence of germline variations in drug transporters ABCB1 and ABCG2 on intracerebral osimertinib efficacy in patients with non-small cell lung cancerG D Marijn Veerman, Rene J Boosman, Merel Jebbink, et al.
Pageof 13